The FDA could still authorize a vaccine for young children by Halloween

Pfizer has asked the Food and Drug Administration to authorize its COVID-19 vaccine for emergency use in children ages 5 to 11, the company and BioNTech announced Thursday. The decision could "help protect more than 28 million people in the United States," writes The New York Times.

If cleared, young children would receive two doses of the Pfizer vaccine three weeks apart — similar to adolescents and adults but at a lower dosage, writes The Wall Street Journal. Experts say they expect the shots to be administered at some schools, pediatrician offices, and certain pharmacies.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Brigid Kennedy

Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.